REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2021

Aug 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS, INC. (REGN)
CIK: 0000872589
Period of Report: 2021-08-16

Reporting Person: SING GEORGE L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-16	Common Stock	S	705	$630.0	Disposed	43858	Direct
2021-08-16	Common Stock	S	1000	$627.5	Disposed	2050	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1150	Indirect
Common Stock	400	Indirect

Footnotes

F1: Represents volume-weighted average price of sales of 1,000 shares of Company stock on August 16, 2021 at prices ranging from $627.37 to $627.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2021 at each separate price.